Current News

Statement of HDMA President and CEO John M. Gray on the Centers for Medicare & Medicaid Services' Proposed AMP Implementation Rule

HDMA Recognized As One of the Best Places to Work in Virginia for Second Year in a Row

HDMA's John M. Gray Highlights 2012 Industry Priorities in Jan. 2 Issue of Chain Drug Review

HDMA Presents Rx Safety and Healthcare Leadership Award to Senator Pat Roberts (R-Kan.)

Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges

Visit HDMA News Center >


print page

 


 

 

Press Release
Contact:
Jeff Van Ness, HDMA, (703) 885-0216
jvanness@hdmanet.org

HDMA COMMENDS FLORIDA GOVERNOR JEB BUSH FOR SIGNING H.B. 371

New Law Strengthens Patient Safety, Medicine Supply Protections Through Strong Chain of Custody Requirements for All Medicines

Arlington, VA—June 27, 2006 —The Healthcare Distribution Management Association (HDMA), representing the nation’s primary, full-service healthcare distributors, applauds Florida Governor Jeb Bush for his leadership to enhance medicine safety and help ensure an uninterrupted supply of medicines for Florida patients. In signing H.B 371, Gov. Bush has extended proven measures to further enhance the security of Florida’s medicine supply and help protect patients from criminal drug counterfeiters. 

“Under H.B. 371, Florida will put in place strong measures that will track the path of each and every medicine sold in Florida, from the manufacturer to the pharmacy,” said HDMA President and CEO John M. Gray. “This legislation was critical to further advance a safe, secure and efficient supply of life-saving medicines. We thank Governor Bush for his ongoing commitment to prescription medicine safety, and we look forward to continuing our work with the Department of Health, law enforcement and our supply chain partners to further improve the security of the healthcare supply chain.”

H.B. 371, which goes into effect on July 1, 2006, will improve tools for Florida law enforcement to find, track and prosecute criminal counterfeiters by requiring comprehensive chain-of-custody pedigrees for all medicines sold in Florida.  H.B. 371 also includes rigorous new data collection requirements for distributors, which will provide a complete audit trail that traces each product back to the manufacturer. These records must be kept, maintained and produced any time they are requested by regulatory authorities or law enforcement. H.B. 371 also maintains the tough distributor licensing and law enforcement measures that took effect in 2003, and expands criminal penalty provisions to make it a felony offense to forge any chain-of-custody document.

The legislation also includes provisions for the safe and efficient “drop-shipment” of critical drugs, including life-saving cancer drugs and emergency products that are required on a time-sensitive basis. Drop-shipped medicines are sent directly from the manufacturer to the pharmacy, hospital or physician’s office.  Tough new recordkeeping and chain-of-custody requirements will apply to these medicines, as well.
 “HDMA’s primary distributor members safely deliver 50 million prescription drugs and healthcare products each year to Florida pharmacies, hospitals, nursing homes, clinics, and physician offices,” continued Gray. “As counterfeiting can happen at any point in the supply chain, strong security measures are needed to help manufacturers, distributors, retailers, law enforcement and lawmakers work together for patient safety. H.B. 371 strengthens medicine safety and security measures that have worked for more than three years by requiring a complete and full transaction history for all products sold in Florida.”

Rep. Ed Homan, M.D. and Sen. Durrell Peaden, M.D. – original sponsors of the Florida’s 2003 Prescription Drug Protection Act– championed the new 2006 legislation, as well as more than 130 Florida pharmacies, hospitals, manufacturers, distributors and other healthcare organizations.

“As a faculty member at the USF School of Medicine and a practicing orthopedic surgeon, I have a vested interest in seeing that my patients, my constituents and all Floridians get the safe medicines they need, when they need them,” said Rep. Ed Homan. “As the sponsor of the landmark 2003 Prescription Drug Protection Act, I can authoritatively say H.B. 371 preserves tough distributor licensing standards and harsh criminal penalties for counterfeiting, and strengthens current law to help ensure that Florida patients continue to receive necessary, authentic medicines daily and in emergency situations.”   

About HDMA
The Healthcare Distribution Management Association (HDMA) is the national association representing primary, full-service healthcare distributors. Each business day, the member companies of HDMA are responsible for ensuring that more than eight million prescription medicines and healthcare products are safely delivered to 145,000 pharmacies, hospitals, nursing homes, physician offices, clinics, government and other providers in all 50 states. This essential public health function is provided with tremendous efficiency, saving the nation’s healthcare system nearly $32 billion each year. HDMA and its members are the vital link in the healthcare system, working daily to provide value, remove costs and develop innovative solutions to deliver care safely and effectively.


 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D
Do you have suggestions
for our site?
URL: